(Q42267194)

19 October 2017

title

Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccine (English)

1 reference

19 October 2017

1 reference

19 October 2017

Lianxing Liu

1 reference

19 October 2017

Yang Huang

series ordinal

1 reference

19 October 2017

Jianqing Xu

series ordinal

1 reference

19 October 2017

Yiming Shao

series ordinal

1 reference

19 October 2017

publication date

11 April 2013

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

page(s)

109-115

1 reference

DNA vaccines: technology and application as anti-parasite and anti-microbial agents

19 October 2017

cites work

2 references

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

21 January 2018

12 December 2020

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

DNA vaccines for viral infections: basic studies and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-013-3303-Z

A preliminary study on the immunogenicity in rabbits and in human volunteers of a recombinant vaccinia virus expressing Epstein-Barr virus membrane antigen

21 January 2018

1 reference

12 December 2020

Plasmid DNA vaccines: assay for integration into host genomic DNA

1 reference

12 December 2020

The prime-boost concept applied to HIV preventive vaccines

1 reference

12 December 2020

1 reference

12 December 2020

[Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice]

1 reference

12 December 2020

Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes

1 reference

12 December 2020

10.1007/S12250-013-3303-Z

Identifiers

DOI

1 reference

19 October 2017

1 reference